Financials

  • Market Capitalization 1.55 B
  • Employee 435
  • Founded 2005
  • CEO N/A
  • Website www.xerispharma.com
  • Headquarter Illinois, United States
  • FIGI BBG012V1MG52
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
Rapporto prezzo/fatturato
4.65

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
2165
BCAX
Bicara Therapeutics Inc. - Common Stock
23.42 USD-5.68%-2.01%-12.87%+62.19%1.55 B USD
2167
LBRX
LB Pharmaceuticals Inc - Common Stock
47.75 USD-0.29%+0.27%+35.89%+151.32%1.54 B USD
2185
TYRA
Tyra Biosciences, Inc. - Common Stock
24.91 USD-4.67%-4.38%-20.47%+73.71%1.49 B USD
2187
INVA
Innoviva, Inc. - Common Stock
20.96 USD0.00%-0.52%-3.68%+17.62%1.51 B USD

Notizie